Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

Innovation for precision therapies 🔬 This Singapore-based biotech develops targeted antibody treatments – reducing the side effects of broad-spectrum therapies.

World Intellectual Property Organization (WIPO)

137,450 subscribers

10,098 views • 10 months ago •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

Research paves the way for new possibilities in cancer care, one discovery at a time. Amgen 🧪🔬🧬’s latest findings highlight: 🔬Innovative approaches for multiple cancer types 📊 New insights into targeted therapies 🌍 The global impact for patients Learn more at #ASCO25

Research paves the way for new possibilities in cancer care, one discovery at a time. Amgen 🧪🔬🧬’s latest findings highlight: 🔬Innovative approaches for multiple cancer types 📊 New insights into targeted therapies 🌍 The global impact for patients Learn more at #ASCO25

Amgen Oncology

237,732 views • 1 year ago

The University of Minnesota leads the way in medical research: 700 NIH-funded projects, including advancing organ transplants, cancer treatments, and Parkinson’s therapies are now at risk. Cutting NIH funding threatens life-saving research and the future of medical innovation.

The University of Minnesota leads the way in medical research: 700 NIH-funded projects, including advancing organ transplants, cancer treatments, and Parkinson’s therapies are now at risk. Cutting NIH funding threatens life-saving research and the future of medical innovation.

Amy Klobuchar

108,284 views • 1 year ago

It is because of the gold standard research conducted at NIH that children with rare diseases are provided the opportunity of lifesaving therapies and treatments. We are proud of our friends at U.S. FDA launching a framework for accelerating the development of individualized therapies for ultra rare diseases. Read more about FDA’s plan to accelerate cures here ➡️ HHS

It is because of the gold standard research conducted at NIH that children with rare diseases are provided the opportunity of lifesaving therapies and treatments. We are proud of our friends at U.S. FDA launching a framework for accelerating the development of individualized therapies for ultra rare diseases. Read more about FDA’s plan to accelerate cures here ➡️ HHS

NIH

22,498 views • 5 months ago

AEI’s Scott Gottlieb, MD 🇺🇸 breaks down the rapid expansion of CAR-T therapies, the implications of the new Psychedelics Executive Order, and efforts to streamline FDA approvals for next-gen treatments.

AEI’s Scott Gottlieb, MD 🇺🇸 breaks down the rapid expansion of CAR-T therapies, the implications of the new Psychedelics Executive Order, and efforts to streamline FDA approvals for next-gen treatments.

American Enterprise Institute

21,956 views • 3 months ago

President Trump signs an executive order to expand research into psychedelic treatments for mental health, directing the FDA to fast-track certain breakthrough therapies. The move aims to help Americans suffering from PTSD and trauma, while ensuring treatments are administered under strict medical supervision. Watch OAN on Spectrum and YouTube TV today for more updates.

President Trump signs an executive order to expand research into psychedelic treatments for mental health, directing the FDA to fast-track certain breakthrough therapies. The move aims to help Americans suffering from PTSD and trauma, while ensuring treatments are administered under strict medical supervision. Watch OAN on Spectrum and YouTube TV today for more updates.

One America News

11,000 views • 3 months ago

Thanks to the leadership of President Trump, under this historic Executive Order, HHS will accelerate research, approval, and access to new mental health treatments, including psychedelic therapies such as ibogaine.

Thanks to the leadership of President Trump, under this historic Executive Order, HHS will accelerate research, approval, and access to new mental health treatments, including psychedelic therapies such as ibogaine.

Secretary Kennedy

251,403 views • 3 months ago

With the goal of advancing cell therapies for patients like JC Cox, MD Anderson has launched the Institute for Cell Therapy Discovery & Innovation. Read more: Katy Rezvani, M.D., Ph.D #EndCancer

With the goal of advancing cell therapies for patients like JC Cox, MD Anderson has launched the Institute for Cell Therapy Discovery & Innovation. Read more: Katy Rezvani, M.D., Ph.D #EndCancer

UT MD Anderson

29,979 views • 1 year ago

At NIH, we’re accelerating the future of medical research, advancing innovation and repurposing existing drugs to deliver new treatments faster for the American people🔬🇺🇸

At NIH, we’re accelerating the future of medical research, advancing innovation and repurposing existing drugs to deliver new treatments faster for the American people🔬🇺🇸

Jay Bhattacharya, MD, PhD

36,018 views • 4 months ago

For millions of Americans, many treatments for mental illness never deliver relief. This is not acceptable. ARPA-H's EVIDENT initiative is awarding up to $139 million to accelerate the research, approval, and responsible access to breakthrough mental health treatments, including psychedelic therapies like ibogaine, to deliver real solutions for Americans with serious mental illness—especially our veterans.

For millions of Americans, many treatments for mental illness never deliver relief. This is not acceptable. ARPA-H's EVIDENT initiative is awarding up to $139 million to accelerate the research, approval, and responsible access to breakthrough mental health treatments, including psychedelic therapies like ibogaine, to deliver real solutions for Americans with serious mental illness—especially our veterans.

Secretary Kennedy

94,859 views • 3 months ago

🇺🇸 The future of medicine is being engineered… and it’s moving fast. Elon dives into the exploding race in synthetic medicine, where biotech and AI are teaming up to create engineered treatments and accelerate drug development like never before. From personalized therapies to massive economic upside, the sector is attracting serious attention from investors and researchers racing to deliver faster, smarter healthcare. Are we on the verge of a biotech revolution? Source: Forbes, Elon Musk

🇺🇸 The future of medicine is being engineered… and it’s moving fast. Elon dives into the exploding race in synthetic medicine, where biotech and AI are teaming up to create engineered treatments and accelerate drug development like never before. From personalized therapies to massive economic upside, the sector is attracting serious attention from investors and researchers racing to deliver faster, smarter healthcare. Are we on the verge of a biotech revolution? Source: Forbes, Elon Musk

Mario Nawfal

78,631 views • 2 months ago

Join us in transforming the way we understand the human genome. Bionano's optical genome mapping workflow provides a comprehensive view of structural variants that impact research and therapies, elevating health and wellness for all. #Bionano #OGM #Innovation #GenomeMapping

Join us in transforming the way we understand the human genome. Bionano's optical genome mapping workflow provides a comprehensive view of structural variants that impact research and therapies, elevating health and wellness for all. #Bionano #OGM #Innovation #GenomeMapping

Bionano

23,683 views • 3 years ago

🚨WHOA! Florida Quietly Drops $140 Million Bombshell: State Backs “Unthinkable” Cancer Research Into Ivermectin, Fasting, and Nutrition-Based Therapies That Could Change Everything While federal agencies continue to guard the pharma-dominated “cut, poison, and burn” model, Florida is moving in the opposite direction — fast. Through its Cancer Innovation Fund, the state has now directed an astonishing $140 million toward high-impact cancer research, funding projects that would be unthinkable in other states — including studies on ivermectin, fasting, and nutrition-based therapies for cancer prevention and treatment. This marks year three of the initiative, and the shift is seismic. For decades, doctors who explored integrative or non-pharmaceutical cancer treatments risked losing their licenses. Now one of America’s largest states is not only protecting that research but funding it. Florida’s message is clear: stop criminalizing innovation, and let science — not pharma — lead. These are 12-month turnaround studies, designed to get data to the public quickly — not buried in bureaucracy or stalled for grants. Vitamin D, metabolic therapies, exercise, and nutrient-based interventions — once dismissed as “alternative” — are now being put under the microscope with state support. If successful, Florida could rewrite the rules of cancer care — proving that healing doesn’t have to come from a pill bottle or a radiation beam. This is the kind of medical independence the rest of the country should be watching.

🚨WHOA! Florida Quietly Drops $140 Million Bombshell: State Backs “Unthinkable” Cancer Research Into Ivermectin, Fasting, and Nutrition-Based Therapies That Could Change Everything While federal agencies continue to guard the pharma-dominated “cut, poison, and burn” model, Florida is moving in the opposite direction — fast. Through its Cancer Innovation Fund, the state has now directed an astonishing $140 million toward high-impact cancer research, funding projects that would be unthinkable in other states — including studies on ivermectin, fasting, and nutrition-based therapies for cancer prevention and treatment. This marks year three of the initiative, and the shift is seismic. For decades, doctors who explored integrative or non-pharmaceutical cancer treatments risked losing their licenses. Now one of America’s largest states is not only protecting that research but funding it. Florida’s message is clear: stop criminalizing innovation, and let science — not pharma — lead. These are 12-month turnaround studies, designed to get data to the public quickly — not buried in bureaucracy or stalled for grants. Vitamin D, metabolic therapies, exercise, and nutrient-based interventions — once dismissed as “alternative” — are now being put under the microscope with state support. If successful, Florida could rewrite the rules of cancer care — proving that healing doesn’t have to come from a pill bottle or a radiation beam. This is the kind of medical independence the rest of the country should be watching.

War Correspondent

129,706 views • 2 months ago

Florida Quietly Drops $140 Million Bombshell: State Backs “Unthinkable” Cancer Research Into Ivermectin, Fasting, and Nutrition-Based Therapies That Could Change Everything While federal agencies continue to guard the pharma-dominated “cut, poison, and burn” model, Florida is moving in the opposite direction — fast. Through its Cancer Innovation Fund, the state has now directed an astonishing $140 million toward high-impact cancer research, funding projects that would be unthinkable in other states — including studies on ivermectin, fasting, and nutrition-based therapies for cancer prevention and treatment. This marks year three of the initiative, and the shift is seismic. For decades, doctors who explored integrative or non-pharmaceutical cancer treatments risked losing their licenses. Now one of America’s largest states is not only protecting that research but funding it. Florida’s message is clear: stop criminalizing innovation, and let science — not pharma — lead. These are 12-month turnaround studies, designed to get data to the public quickly — not buried in bureaucracy or stalled for grants. Vitamin D, metabolic therapies, exercise, and nutrient-based interventions — once dismissed as “alternative” — are now being put under the microscope with state support. If successful, Florida could rewrite the rules of cancer care — proving that healing doesn’t have to come from a pill bottle or a radiation beam. This is the kind of medical independence the rest of the country should be watching.

Florida Quietly Drops $140 Million Bombshell: State Backs “Unthinkable” Cancer Research Into Ivermectin, Fasting, and Nutrition-Based Therapies That Could Change Everything While federal agencies continue to guard the pharma-dominated “cut, poison, and burn” model, Florida is moving in the opposite direction — fast. Through its Cancer Innovation Fund, the state has now directed an astonishing $140 million toward high-impact cancer research, funding projects that would be unthinkable in other states — including studies on ivermectin, fasting, and nutrition-based therapies for cancer prevention and treatment. This marks year three of the initiative, and the shift is seismic. For decades, doctors who explored integrative or non-pharmaceutical cancer treatments risked losing their licenses. Now one of America’s largest states is not only protecting that research but funding it. Florida’s message is clear: stop criminalizing innovation, and let science — not pharma — lead. These are 12-month turnaround studies, designed to get data to the public quickly — not buried in bureaucracy or stalled for grants. Vitamin D, metabolic therapies, exercise, and nutrient-based interventions — once dismissed as “alternative” — are now being put under the microscope with state support. If successful, Florida could rewrite the rules of cancer care — proving that healing doesn’t have to come from a pill bottle or a radiation beam. This is the kind of medical independence the rest of the country should be watching.

Camus

356,515 views • 8 months ago

2024 was a landmark year for builders. From AI fortifying our national infrastructure, to breakthroughs in diagnostics and targeted drug therapies, to the acceleration of edge computing and consumer AI adoption. Here’s the most-read and most-watched content from a16z this year. 🔗👇

2024 was a landmark year for builders. From AI fortifying our national infrastructure, to breakthroughs in diagnostics and targeted drug therapies, to the acceleration of edge computing and consumer AI adoption. Here’s the most-read and most-watched content from a16z this year. 🔗👇

a16z

134,832 views • 1 year ago

Robert Kennedy Jr. has exposed a harsh reality: therapies like chelating compounds, ivermectin, hydroxychloroquine, hyperbaric treatments, and stem cells are often suppressed because they can’t be patented by big pharmaceutical companies. If it doesn’t guarantee profits, it’s criticized, mocked, or outright blocked from public access. This system prioritizes profit over health, and it must be challenged. It’s time to push for the freedom to access life-saving, natural, and alternative therapies.

Robert Kennedy Jr. has exposed a harsh reality: therapies like chelating compounds, ivermectin, hydroxychloroquine, hyperbaric treatments, and stem cells are often suppressed because they can’t be patented by big pharmaceutical companies. If it doesn’t guarantee profits, it’s criticized, mocked, or outright blocked from public access. This system prioritizes profit over health, and it must be challenged. It’s time to push for the freedom to access life-saving, natural, and alternative therapies.

Lance Wallnau

12,091 views • 1 year ago

100% Cancer Remission Achieved in ALL Patients of Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.

100% Cancer Remission Achieved in ALL Patients of Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.

The Vigilant Fox 🦊

2,527,485 views • 2 years ago

100% Cancer Remission Achieved in ALL Patients in Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Cercek explained that it essentially unlocks the body’s ability to heal itself.

100% Cancer Remission Achieved in ALL Patients in Groundbreaking Study Dr. Andrea Cercek, one of the lead researchers, said: “It’s absolutely incredible ... We’ve certainly never seen this before.” All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies. The authors wrote: “All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.” How does this monoclonal antibody actually work? Dr. Cercek explained that it essentially unlocks the body’s ability to heal itself.

The Vigilant Fox 🦊

1,600,275 views • 2 years ago

A magnetically guided microrobotics system is capable of navigating the body’s intricate passageways and vasculature to deliver drugs with pinpoint accuracy, according to a new study in Science. The novel system could enable safer, targeted drug treatments that minimize unwanted side effects.

A magnetically guided microrobotics system is capable of navigating the body’s intricate passageways and vasculature to deliver drugs with pinpoint accuracy, according to a new study in Science. The novel system could enable safer, targeted drug treatments that minimize unwanted side effects.

Science Magazine

20,805 views • 8 months ago